The objective was to evaluate the efficacy of [TIMP-2] × [IGFBP-7] in identifying individuals at high risk for AKI, with a high sensitivity cutoff of >0.3 (ng/mL)2/1000. The gene discussed is IGFBP7; the disease is acute kidney injury.